|
1
|
Del Duca G, Tavelli A, Mastrorosa I, Aguglia C, Lanini S, Brita AC, Gagliardini R, Vita S, Vergori A, Paulicelli J, Natalini G, D’Urso A, Piselli P, Gallì P, Mondillo V, Mastroianni C, Tamburrini E, Sarmati L, Stingone C, Lichtner M, Nicastri E, Farinella M, Leserri F, Siddu A, Maggi F, d’Arminio Monforte A, Vairo F, Barca A, Vaia F, Girardi E, Mazzotta V, Antinori A. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis. Vaccines (Basel) 2023; 11:1761. [PMID: 38140166 PMCID: PMC10748194 DOI: 10.3390/vaccines11121761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 11/16/2023] [Accepted: 11/23/2023] [Indexed: 12/24/2023] Open
Abstract
BACKGROUND we aim to investigate attitudes toward vaccination by analyzing empirical factors associated with vaccine acceptance in the Lazio region mpox vaccination (MpoxVax) campaign in Italy. METHODS all subjects who accessed MpoxVax and signed the informed consent were prospectively enrolled in the MPOX-VAC Study and were asked to fill out an anonymous survey. Two endpoints were selected: 'delayed acceptance' and 'early acceptance', defined as access for vaccination >60 and ≤30 days from the vaccination campaign starting (VCS), respectively. RESULTS over the study period, 1717 individuals underwent vaccination: 129 (7%) > 60 [1588 (92.5%) ≤ 60] and 676 (60%) ≤ 30 days from VCS. A bisexual orientation, a lower education level and a worse perceived physical and mental health were associated with delayed access to vaccination. Being pre-exposure prophylaxis (PrEP) users and, marginally, HIV positive; having a high perceived risk for mpox infection; and reporting high-risk behaviors like the use of recreational drugs/chems, sex under the influence of drugs and/or alcohol and having a higher number of principal sexual partners, were associated with early access to vaccination. CONCLUSIONS according to our data, risk awareness was a major determinant of early MpoxVax acceptance. Conversely, worse perceived health status and a low educational level were critical factors associated with delayed vaccination.
Collapse
Affiliation(s)
- Giulia Del Duca
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | | | - Ilaria Mastrorosa
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Camilla Aguglia
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
- Department of System Medicine, University of Rome Tor Vergata, 00133 Rome, Italy;
| | - Simone Lanini
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Anna Clelia Brita
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Roberta Gagliardini
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Serena Vita
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Alessandra Vergori
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Jessica Paulicelli
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Giorgia Natalini
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Angela D’Urso
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Pierluca Piselli
- Department of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (P.P.); (F.V.)
| | - Paola Gallì
- Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (P.G.); (V.M.)
| | - Vanessa Mondillo
- Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (P.G.); (V.M.)
| | - Claudio Mastroianni
- Department of Public Health and Infectious Diseases, Sapienza University, AOU Policlinico Umberto 1, 00161 Rome, Italy;
| | - Enrica Tamburrini
- Fondazione Policlinico A. Gemelli, Catholic University of the Sacred Heart, 00168 Rome, Italy;
| | - Loredana Sarmati
- Department of System Medicine, University of Rome Tor Vergata, 00133 Rome, Italy;
| | - Christof Stingone
- STI/HIV Unit, San Gallicano IRCCS Dermatological Institute, 00144 Rome, Italy;
| | - Miriam Lichtner
- Neuroscience Mental Health and Sense Organs Department, Sapienza University of Rome, Polo Pontino, 04100 Latina, Italy;
| | - Emanuele Nicastri
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | | | | | - Andrea Siddu
- General Directorate of Prevention, Ministry of Health, 00197 Rome, Italy; (A.S.); (F.V.)
| | - Fabrizio Maggi
- Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy;
| | | | - Francesco Vairo
- Department of Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (P.P.); (F.V.)
| | - Alessandra Barca
- Unit of Health Promotion and Prevention, Directorate of Health and Integration, Lazio Region, 00145 Rome, Italy;
| | - Francesco Vaia
- General Directorate of Prevention, Ministry of Health, 00197 Rome, Italy; (A.S.); (F.V.)
| | - Enrico Girardi
- Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy;
| | - Valentina Mazzotta
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| | - Andrea Antinori
- Clinical Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy; (G.D.D.); (C.A.); (S.L.); (A.C.B.); (R.G.); (S.V.); (A.V.); (J.P.); (G.N.); (A.D.); (E.N.); (V.M.); (A.A.)
| |
Collapse
|